These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11591605)
1. Report from the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001. Fleming T; Lindenfeld J; Lipicky R; Armstrong P Circulation; 2001 Oct; 104(15):1742. PubMed ID: 11591605 [No Abstract] [Full Text] [Related]
2. Report From the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001. SoRelle R Circulation; 2001 Aug; 104(9):E9017-8. PubMed ID: 11526948 [No Abstract] [Full Text] [Related]
3. Drug therapy for pulmonary arterial hypertension: what's on the menu today? Mehta S Chest; 2003 Dec; 124(6):2045-9. PubMed ID: 14665473 [No Abstract] [Full Text] [Related]
4. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension. Shimizu M; Imanishi J; Takano T; Miwa Y Intern Med; 2011; 50(20):2341-6. PubMed ID: 22001462 [TBL] [Abstract][Full Text] [Related]
5. A new era in the treatment of primary pulmonary hypertension. Bailey CL; Channick RN; Rubin LJ Heart; 2001 Mar; 85(3):251-2. PubMed ID: 11179256 [No Abstract] [Full Text] [Related]
6. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Hoeper MM; Taha N; Bekjarova A; Gatzke R; Spiekerkoetter E Eur Respir J; 2003 Aug; 22(2):330-4. PubMed ID: 12952269 [TBL] [Abstract][Full Text] [Related]
7. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion? Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133 [TBL] [Abstract][Full Text] [Related]
8. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849 [TBL] [Abstract][Full Text] [Related]